They aren't just "pandemic stocks." ...
U.S. regulators authorized Moderna Inc’s COVID-19 vaccine for emergency use on Friday, a week after granting the first U.S. authorization to Pfizer Inc and BioNTech SE’s coronavirus shot. Both ...
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech traded blows this week with rival Moderna as dueling decisions came down in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results